Astrazeneca Pharma India Board of Directors
Get the latest insights into the leadership at Astrazeneca Pharma India. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Ms. Shilpa Divekar Nirula | Chairperson & Independent Director |
| Mr. Praveen Rao Akkinepally | Managing Director |
| Ms. Bhavana Agrawal | Executive Director |
| Ms. Sylvia Lorena Varela Ramon | Non Executive Director |
| Ms. Hooi Bien Chuah | Non Executive Director |
| Mr. Jesus Javier Diaz-Ropero Esteso | Non Executive Director |
| Ms. Revathy Ashok | Independent Director |
| Ms. Monica Widhani | Independent Director |
Astrazeneca Pharma India Share price
ASTRAZEN
8460.5
131.50 (1.58%)NSE
BSE
Last updated on 29 Aug, 2025 | 15:30 IST
BUYSELL
Today's High
8514.50
Today's Low
8287.00
52 Week Low
6220.00
52 Week High
10691.00
The current prices are delayed, login to your account for live prices
LoginAstrazeneca Pharma India FAQs
The board at Astrazeneca Pharma India consists of experienced professionals, including Ms. Shilpa Divekar Nirula , Mr. Praveen Rao Akkinepally , and others, overseeing the company’s strategic and corporate governance.
Directors at Astrazeneca Pharma India are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Ms. Shilpa Divekar Nirula is the current chairman at Astrazeneca Pharma India.
Executive directors at Astrazeneca Pharma India are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Astrazeneca Pharma India adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Astrazeneca Pharma India, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.